Diagnosis and treatment of VOD/SOS after allogeneic hematopoietic stem cell transplantation

F Bonifazi, F Barbato, F Ravaioli, M Sessa… - Frontiers in …, 2020 - frontiersin.org
Hepatic veno-occlusive disease (VOD) or sinusoidal obstruction syndrome (SOS) is a rare
complication characterized by hepatomegaly, right-upper quadrant pain, jaundice, and …

Characteristics and treatment rate of patients with hepatitis C virus infection in the direct-acting antiviral era and during the COVID-19 pandemic in the United States

VH Nguyen, L Kam, YH Yeo, DQ Huang… - JAMA Network …, 2022 - jamanetwork.com
Importance Clinical data on hepatitis C virus (HCV) treatment rates in the United States are
sparse. Objective To evaluate HCV treatment rates in the era of direct-acting antivirals …

Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the American Association for the Study of …

GY Im, JL Mellinger, A Winters, ES Aby… - Clinical …, 2021 - Elsevier
Background & Aims While abstinence-promoting behavioral and pharmacotherapies are
part of the therapeutic foundation for alcohol use disorder (AUD) and alcohol-associated …

[HTML][HTML] 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations

ML Yu, PJ Chen, CY Dai, TH Hu, CF Huang… - Journal of the Formosan …, 2020 - Elsevier
Hepatitis C virus (HCV) infection is a silent killer that leads to rapid progression of liver
cirrhosis and hepatocellular carcinoma (HCC). High prevalence of HCV infection has been …

Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects

B Guo, Q Chen, Z Liu, X Chen, P Zhu - Frontiers in Oncology, 2023 - frontiersin.org
Curative surgical treatments, mainly liver resection, are still one of the optimal options for
patients with early-, mid-, and even progression-stage hepatocellular carcinoma (HCC) …

Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma

ND Parikh, N Mehta, MA Hoteit, JD Yang, BV John… - Cancer, 2022 - Wiley Online Library
Background Sustained viral response (SVR) improves survival for patients with hepatitis C
(HCV) and hepatocellular carcinoma (HCC) after curative treatment; however, the benefit of …

Assessment of incidence of and surveillance burden for hepatocellular carcinoma among patients with hepatitis C in the era of direct-acting antiviral agents

Q Chen, T Ayer, MG Adee, X Wang, F Kanwal… - JAMA network …, 2020 - jamanetwork.com
Importance In the US, hepatocellular carcinoma (HCC), primarily associated with hepatitis C
virus (HCV) infection, is the fastest rising cause of cancer-related death. Wider use of highly …

Provider attitudes toward risk-based hepatocellular carcinoma surveillance in patients with cirrhosis in the United States

NJ Kim, K Rozenberg-Ben-Dror, DA Jacob… - Clinical …, 2022 - Elsevier
Background & Aims Hepatocellular carcinoma (HCC) surveillance rates are suboptimal in
clinical practice. We aimed to elicit providers' opinions on the following aspects of HCC …

[HTML][HTML] Changing trends of cirrhotic and noncirrhotic hepatocellular carcinoma in the era of directly-acting antiviral agents

K Mathur, A Mazhar, M Patel, L Dakhoul… - Clinical and …, 2021 - journals.lww.com
METHODS: Clinical characteristics including presence or absence of underlying cirrhosis
were collected from 2,623 patients diagnosed with HCC between 2009 and 2019 at 2 large …

[HTML][HTML] Practice habits, knowledge, and attitudes of hepatologists to alcohol use disorder medication: sobering gaps and opportunities

TG Cotter, F Ayoub, AC King, KG Reddy… - Transplantation …, 2020 - journals.lww.com
Background: The prevalence of alcohol use disorder (AUD) and alcohol-associated liver
disease is increasing in the United States. Efficacious AUD pharmacotherapies, while …